Leveraging ligand density and multivalent binding for optimal mannose targeting of APCs in precision vaccines.

Precise targeting of antigen-presenting cells (APCs) via mannose is a classic vaccine strategy, but traditional random conjugation often fails to mimic natural pathogen glycan arrays, limiting receptor cross-linking and risking immune tolerance. This review systematically decodes the critical geometric thresholds of nanointerfaces regulating mannose targeting. We elucidate how optimal ligand spacing and density synergistically trigger the 'glycosyl cluster effect' for efficient receptor aggregation, contrasting the biophysical recognition between rigid polymers and fluid lipid nanoparticles (LNPs). To transform targeted uptake into potent adaptive immunity, we further analyze post-endocytosis intracellular transport. We emphasize coupling interface recognition with pH-responsive endosomal escape mechanisms to rescue antigens from lysosomal degradation, redirecting them toward MHC-I cross-presentation for robust CD8 + T cell responses. Finally, addressing field fragmentation, we innovatively propose the "Minimum Information About a Carbohydrate Agent (MIACA)" framework for glycan-based nano-carriers, to mandate the evaluation of effective ligand density, binding kinetics, and spatial bioavailability, providing an engineering blueprint for clinically translatable precision vaccines.